Health Canada changes course on COVID testing at home

Published 2020-09-04, 10:01 p/m
© Reuters. The number of novel coronavirus cases continues to grow in Toronto
ABT
-

TORONTO (Reuters) - Health Canada is willing to consider approving home COVID-19 tests to screen for the virus, a spokesman for the minister of health told Reuters, in a win for public health experts and doctors who have argued that frequent and inexpensive testing could beat back the pandemic.

The health ministry had previously said it was concerned that people might misuse home tests or misinterpret the results.

"In response to the evolution of the pandemic, Health Canada is now considering applications for home testing devices for screening purposes," said Cole Davidson, spokesman for the minister of health said in a statement.

In June 2020, Health Canada had indicated that it would not review applications for home test kits, as at that time, "the Department's position was in relation to the use of home tests for diagnostic purposes," the statement said.

Screening tests are meant to monitor large groups of seemingly healthy people for illness, while diagnostic tests investigate symptoms.

The change could allow for self collection, where samples are sent to a lab for processing, and spur the development of new tests to detect the virus at home.

Home tests may be more likely to miss positive cases than the laboratory tests. Regulators generally want those errors to be vanishingly rare, since patients who do not realize they are contagious could spread the virus.

But advocates argue that cheap, rapid tests could more than make up for any reduced sensitivity if they can be used to test many people daily or weekly, and are very unlikely to miss people who are sick enough to be contagious.

Rapid COVID tests similar to home pregnancy tests exist as prototypes in research labs, but until last week none were approved or manufactured at scale.

Last week the U.S. Food and Drug Administration approved a $5 rapid COVID test about the size of a credit card, made by Abbott Laboratories (NYSE:ABT). The test cannot be taken alone, but it can be administered by a wide variety of healthcare providers and technicians.

© Reuters. The number of novel coronavirus cases continues to grow in Toronto

Abbott has not applied to sell the device in Canada, public application data shows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.